JP2007511493A5 - - Google Patents

Download PDF

Info

Publication number
JP2007511493A5
JP2007511493A5 JP2006538953A JP2006538953A JP2007511493A5 JP 2007511493 A5 JP2007511493 A5 JP 2007511493A5 JP 2006538953 A JP2006538953 A JP 2006538953A JP 2006538953 A JP2006538953 A JP 2006538953A JP 2007511493 A5 JP2007511493 A5 JP 2007511493A5
Authority
JP
Japan
Prior art keywords
autoimmune
use according
vascular
disorder
rhodococcus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006538953A
Other languages
English (en)
Other versions
JP2007511493A (ja
JP4875494B2 (ja
Filing date
Publication date
Priority claimed from GB0326620A external-priority patent/GB0326620D0/en
Priority claimed from GB0404102A external-priority patent/GB0404102D0/en
Application filed filed Critical
Priority claimed from PCT/GB2004/004783 external-priority patent/WO2005049056A2/en
Publication of JP2007511493A publication Critical patent/JP2007511493A/ja
Publication of JP2007511493A5 publication Critical patent/JP2007511493A5/ja
Application granted granted Critical
Publication of JP4875494B2 publication Critical patent/JP4875494B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (12)

  1. 自己免疫疾患又は自己免疫異常を治療又は予防するための医薬品の製造における、ロドコッカス属、ゴルドニア属、ノカルジア属、ダイエツィア属、ツカムレラ属及びノカルジオイデス属の1又は2以上の属に属する細菌の全細胞を含む免疫調節物質組成物又は薬剤組成物の使用。
  2. 自己免疫疾患又は自己免疫異常が血管内膜の炎症を含む、請求項1に記載の使用。
  3. 自己免疫疾患又は自己免疫異常が血管筋層又は心筋の炎症をさらに含む、請求項2に記載の使用。
  4. 自己免疫疾患又は自己免疫異常が、血管障害が先行するもの又は血管障害に起因するものである、請求項1から3のいずれか一項に記載の使用。
  5. 自己免疫疾患又は自己免疫異常が、関節炎、特に関節リウマチ、乾癬、乾癬性関節症、強皮症、甲状腺炎、移植後の内膜増殖、移植片拒絶及び血管障害の1又は2以上から選択される、請求項1から4のいずれか一項に記載の使用。
  6. 血管障害が、自己免疫エレメントを含む血管障害である、請求項5に記載の使用。
  7. 血管障害が、レイノー病又はレイノー現象、前部ブドウ膜炎、閉塞性血管障害、(動脈硬化症としても知られる)アテローム形成、動脈炎、(自然又は血管形成術後の)筋内膜増殖、血管の内膜及び/又は筋層の炎症性及び自己免疫性肥厚、炎症性血管病変、アテローム硬化性心疾患、再潅流傷害、心臓伝導障害、心筋炎、心筋梗塞の1又は2以上から選択される、請求項5又は請求項6に記載の使用。
  8. 移植片拒絶が慢性移植片拒絶である、請求項5に記載の使用。
  9. 移植片拒絶が免疫抑制薬の非存在下の慢性移植片拒絶である、請求項5に記載の使用。
  10. 細菌が、ゴルドニア・ブロンチアリス、ゴルドニア・アマレア、ゴルドニア・スプチ、ゴルドニア・テレア、ノカルジア・アステロイド、ダイエツィア・マリス、ツカムレラ・パウロメタボラ、ロドコッカス・ルベル、ロドコッカス・ロドニイ、ロドコッカス・コルプロフィラス、ロドコッカス・オパカス、ロドコッカス・エリトポレス、ノカルジオイデス・アルバス及びツカムレラ・インコネンシスからなる群の1又は2以上から選択される、請求項1から9のいずれか一項に記載の使用。
  11. 細菌を死滅させる、請求項1から10のいずれか一項に記載の使用。
  12. 請求項1から11に実質的に記載された使用。
JP2006538953A 2003-11-14 2004-11-12 免疫調節物質 Expired - Fee Related JP4875494B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0326620A GB0326620D0 (en) 2003-11-14 2003-11-14 Immune modulator
GB0326620.2 2003-11-14
GB0404102A GB0404102D0 (en) 2004-02-24 2004-02-24 Immune modulator
GB0404102.6 2004-02-24
PCT/GB2004/004783 WO2005049056A2 (en) 2003-11-14 2004-11-12 Immune modulator comprising whole cell rhodococcus, gordonia, nocardia, dietzia, tsukamurella or nocardioides bacteria

Publications (3)

Publication Number Publication Date
JP2007511493A JP2007511493A (ja) 2007-05-10
JP2007511493A5 true JP2007511493A5 (ja) 2007-10-25
JP4875494B2 JP4875494B2 (ja) 2012-02-15

Family

ID=34621659

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006538953A Expired - Fee Related JP4875494B2 (ja) 2003-11-14 2004-11-12 免疫調節物質

Country Status (9)

Country Link
US (1) US7413728B2 (ja)
EP (1) EP1684803B1 (ja)
JP (1) JP4875494B2 (ja)
AR (1) AR046583A1 (ja)
AT (1) ATE473014T1 (ja)
DE (1) DE602004028038D1 (ja)
ES (1) ES2347566T3 (ja)
GB (1) GB2422544B (ja)
WO (1) WO2005049056A2 (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8501198B2 (en) 2004-06-07 2013-08-06 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US7442374B2 (en) 2004-07-19 2008-10-28 Ucl Biomedica Plc Composition for increasing the survival to slaughter rate of piglets
GB0526033D0 (en) 2005-12-21 2006-02-01 Bioeos Ltd Method
GB0526032D0 (en) * 2005-12-21 2006-02-01 Bioeos Ltd Use
EP2170082A4 (en) * 2007-06-29 2012-01-11 Commw Scient Ind Res Org PROCESS FOR REMOVING TOXIC COMPOUNDS
GB0716778D0 (en) 2007-08-29 2007-10-10 Bioeos Ltd Use
US20110092589A1 (en) * 2008-03-10 2011-04-21 The Charlotte-Mecklenburg Hospotal Authority Treatment of Inflammatory Conditions and Diseases with Metal-Thiols
EP3235506B1 (en) * 2010-07-26 2023-12-06 Qu Biologics Inc. Immunogenic anti-inflammatory compositions
US8980279B2 (en) 2010-07-26 2015-03-17 Qu Biologics Personalized site-specific immunomodulation
CN106456740B (zh) 2014-05-02 2021-06-08 Qu生物制药公司 抗微生物免疫调节
AU2017222692A1 (en) * 2016-02-25 2018-09-27 Thomas Julius Borody Compositions and methods of treatment of chronic infectious diseases
KR20210114436A (ko) * 2019-01-15 2021-09-23 랴오닝 그레이티스트 바이오-파마슈티컬 컴퍼니 리미티드 로도코커스 루버로부터 유래하는 생성물 및 이의 약학 용도

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL71683A0 (en) 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
US4599310A (en) * 1984-06-18 1986-07-08 Bristol-Myers Company Process for producing antitumor antibiotic compound
GB9203814D0 (en) 1992-02-21 1992-04-08 Univ London Treatment of long term auto-immune conditions
ES2128093T3 (es) * 1994-10-12 1999-05-01 Du Pont Procedimiento enzimatico para la preparacion de esteres de acidos carboxilicos quirales alfa-terciarios.
JPH10117633A (ja) * 1996-10-21 1998-05-12 Mitsui Pharmaceut Inc 遺伝子欠損動物
KR100250830B1 (ko) * 1997-12-09 2000-04-01 성재갑 자가분해에 의해 폴리하이드록시알킨산으로부터 광학활성을 가진 단량체 하이드록시카르복실산의 제조방법
AU3344299A (en) * 1998-04-20 1999-11-08 Shionogi & Co., Ltd. Th2-migration promoters containing w/o emulsions
DE69911401T2 (de) * 1998-05-20 2004-06-24 Erasmus Universiteit Rotterdam Immunoregulator
JPWO2002056911A1 (ja) * 2000-12-26 2004-05-20 味の素株式会社 移植拒絶反応抑制剤
WO2003014309A2 (en) * 2001-08-07 2003-02-20 Immunex Corporation Interleukin-1 receptors in the treatment of diseases
NZ555055A (en) * 2001-12-11 2010-06-25 Pasteur Institut Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
WO2004022093A1 (en) 2002-09-06 2004-03-18 University College London Whole bacterial cells as immune modulator

Similar Documents

Publication Publication Date Title
JP2007511493A5 (ja)
WO2007015906A3 (en) Methods and compositions for smooth muscle reconstruction
EA200700212A1 (ru) Многовалентные vla-4 антагонисты, содержащие полимерные фрагменты
JP2011504474A5 (ja)
EP2380969A3 (en) Perivascular mesenchymal precursor cell induced blood vessel formation
WO2010057112A3 (en) Genetic variants underlying human cognition and methods of use thereof as diagnostic and therapeutic targets
WO2007024441A3 (en) Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof
AR021893A1 (es) Compuesto de 2-fenil-1-(3,4-dihidroxi-5-nitrofenil)-1-etanona sustituida , su uso para la manufactura de un medicamento en el tratamiento de algunos trastornos del sistema nervioso central y periférico y composiciones farmacéuticas que las contienen
WO2004096245A3 (en) Muscle derived cells (mdcs) for promoting and enhancing nerve repair and regeneration
UA88634C2 (en) Quaternized quinuclidine esters
Berrios et al. Depressive illness in multiple sclerosis
MX2007000046A (es) Compuestos, composiciones y metodos de imidazolo relacionados para su uso.
WO2007035722A3 (en) Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
Chiba et al. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate
JP2009519216A5 (ja)
Krantz et al. Repetitive yawning associated with cardiac tamponade
TW200745087A (en) CCR5 antagonists useful for treating HIV
Webster et al. Fluoroquinolone resistance in renal isolates of Mycobacterium tuberculosis
WO2007069927A3 (en) Methods of the obtaining of olfactory ensheathing cells and their application
Raman et al. The Madras Leper Hospital and leprosy management in 19th century
TW200640910A (en) Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors
WO2005103711A3 (en) Diagnostics and therapeutics for diseases associated with cxc chemokine receptor 1 (cxcr1)
WO2004104577A3 (en) Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 4 (5-ht4)
Alahmed Oral Findings and Buccal Micronucleus Cytome Assay in patients with Rheumatoid arthritis on Methotrexate and Etanercept treatments
Grosso et al. Haploidentical Transplantation In Adults≥ 66 Years of Age